cGxP.wire https://validator.w3.org/feed/docs/rss2.html Guardant Health Secures FDA Nod for HER2-Mutant NSCLC Diagnostic FDA Authorizes First Generic Treatment for New World Screwworm Lilly’s Jaypirca Reduces Risk of Disease Progression or Death by 45% in CLL/SLL JW Pharmaceutical Showcases DDC-02 Potential Across Multiple Rare Neurodevelopmental Disorders at WODC USA 2026 AstraZeneca’s Truqap Becomes First Targeted Therapy Approved for PTEN-Deficient Prostate Cancer FDA Clears Dexcom Stelo OTC CGM for Children Menarini Reports Positive Phase 3 SENTRY Data at EHA Genmab Reports Positive EPCORE FL-1 Data for Epcoritamab Combination Gan & Lee Showcases Metabolic Pipeline Data at ADA 2026 Lateral Pharma Strengthens Pain Therapeutics Pipeline with LANCL1 Discovery Roche Advances Precision Oncology with PTEN Diagnostic Approval Johnson & Johnson Reveals Promising Phase 3 Results for Bispecific Myeloma Therapy AbbVie Reports 9-Year VENCLEXTA Data in First-Line CLL Lyell Immunopharma Showcases Updated Ronde-Cel Data at EHA 2026 Harbour BioMed Secures Major Antibody Patent Victory Over Amgen Agios Highlights RISE UP Phase 3 Results at EHA 2026 Rznomics Highlights Early Clinical Activity of RZ-001 at ASNO 2026 CARsgen Reports Promising Allogeneic CAR-T Data at EHA Volta Labs Automates Twist’s Full Hybrid Capture Portfolio on Callisto Rein Therapeutics Expands Phase 2 RENEW Trial into the UK IGC Pharma Completes Enrollment in Phase 2 CALMA Trial Arima Genomics Reports Hi-C Outperforms Whole Genome Sequencing Kos Biotechnology Partners Closes $123M Life Sciences Fund MGI Tech Expands Genomics Ecosystem at ESHG 2026 CytoDyn Doses First Patient in Phase 2a Alzheimer’s Trial of Leronlimab Johnson & Johnson Expands TECNIS PureSee IOL Access Heartseed Initiates World’s First Catheter-Based iPS Heart Therapy Study Novo Nordisk Secures UK Approval for First Wegovy Weight-Loss Pill IMDx GraftAssure Assay Demonstrates Superior Accuracy for Kidney Transplant Rejection Monitoring Datasea Advances FDA Compliance for Acoustic BCI Device Sanofi’s Tzield Gains FDA Approval in Stage 3 Type 1 Diabetes HUTCHMED Reports Positive Phase III Sovleplenib Results in wAIHA Jazz Reports Phase 3 LAGOON Results for Zepzelca in SCLC GlycoNex Reports Positive Phase III Results for SPD8 Biosimilar Wave Neuroscience Wins FDA Clearance for MeRT in PTSD Simcere and Stanford Partner on Novel IPF Therapy Research Novartis Advances First Targeted Therapy for Chronic Inducible Urticaria XtalPi Advances AI-Powered Drug Discovery Through $400M GPCR Collaboration Akeso Wins NMPA Approval for Gumokimab in Plaque Psoriasis FDA Grants Priority Review to Genentech’s Tecentriq for Early Colon Cancer Merck Animal Health Acquires TARGAN to Advance Poultry Technology Immunome Doses First Patient in Phase 1 Trial of IM-1617 Penumbra Gains FDA Approval for THUNDERBOLT Thrombectomy System ZYUS Life Sciences Realigns Operations to Advance Non-Opioid Drug Pipeline Xeris Pharmaceuticals Receives USPTO Patent Allowance for KEVEYIS Roche Expands VENTANA MMR Companion Diagnostic Across Multiple Cancer Types Airiver Treats First Patient in Pivotal CRS Balloon Trial Roche’s Tecentriq Receives FDA Priority Review for Stage III Colon Cancer DKSH and BridgeBio Partner to Expand ATTR-CM Treatment Access Elixiron Reports Positive Phase 2 Enrupatinib Data in Alzheimer’s Disease